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Over the last decades, research dedicated to the molecular and cellular mechanisms under-
lying primary immunodeficiencies (PID) has helped to understand the etiology of many
of these diseases and to develop novel therapeutic approaches. Beyond these aspects,
PID are also studied because they offer invaluable natural genetic tools to dissect the
human immune system. In this review, we highlight the research that has focused over
the last 20 years on T lymphocytes from Wiskott–Aldrich syndrome (WAS) patients. WAS
T lymphocytes are defective for the WAS protein (WASP), a regulator of actin cytoskele-
ton remodeling. Therefore, study of WAS T lymphocytes has helped to grasp that many
steps of T lymphocyte activation and function depend on the crosstalk between mem-
brane receptors and the actin cytoskeleton. These steps include motility, immunological
synapse assembly, and signaling, as well as the implementation of helper, regulatory, or
cytotoxic effector functions. The recent concept that WASP also works as a regulator of
transcription within the nucleus is an illustration of the complexity of signal integration in
T lymphocytes. Finally, this review will discuss how further study of WAS may contribute
to solve novel challenges of T lymphocyte biology.
Keywords:Wiskott–Aldrich syndrome,T lymphocytes, actin cytoskeleton, motility, immunological synapse, signal-
ing, transcription
GENERAL PRESENTATION OF THE WISKOTT–ALDRICH
SYNDROME
The Wiskott–Aldrich syndrome (WAS) is an X-linked primary
immunodeficiency (PID) characterized by the association of mul-
tiple clinical manifestations. Depending on disease severity, WAS
patients may display susceptibility to viral, bacterial, and fungal
infections, hemorrhages, eczema, multiple forms of autoimmune
disorders, and susceptibility to develop hematological malignan-
cies (1). The genetic defect at the origin of WAS has been identified
20 years ago (2), as mutations in the previously unknown gene
encoding the WAS protein (WASP). This discovery has paved
the way to the elucidation of WASP function. WASP expression
is restricted to precursor and mature cells of the hematopoi-
etic lineage (3), in which it promotes Arp2/3-dependent actin
polymerization as an effector of the Rho GTPase Cdc42 (4, 5).
Most of the defects associated with defective or abnormal WASP
expression arise in mature hematopoietic cells rather than in their
precursors. The nature of the mutations in the WAS gene and
their consequence on the expression of WASP in hematopoietic
cells correlate with the severity of the disease. The WASP-related
pathologies include classical WAS (usually associated with defec-
tive WASP), X-linked thrombocytopenia (XLT, caused by residual
point-mutated WASP), and X-linked neutropenia (XLN, caused
by activating mutations). Over the last two decades, hundreds of
studies have provided insights into how WASP regulates the acti-
vation and function of the different subsets of hematopoietic cells
in which it is normally expressed (6). This has led to the notion
that WAS results from the combination of a myriad of hematopoi-
etic cell defects. In that respect, WASP deficiency illustrates how
a single protein may participate in distinct functions in different
cells (7). The ability of WASP to execute multiple tasks is linked
to the fact that actin cytoskeleton remodeling is supporting many
dynamic aspects of cell biology and that the different hematopoi-
etic cells execute specific functions relying on a dynamic actin
cytoskeleton.
The objective of this review is not to draw a comprehensive map
of the functions executed by WASP in the numerous hematopoi-
etic subsets. Instead, we will focus on the role played by WASP
in T lymphocytes and will highlight how this line of research has
contributed to our current understanding of signal integration
during T lymphocyte activation and function. By attempting to
link-specific WAS-related T lymphocytes defects to the clinical
manifestations arising in WAS patients, we will also discuss how
the study of WAS is helping us to understand the function of
human T lymphocytes in vivo.
ROLE OF WASP IN THE MOLECULAR CONTROL OF T CELL
ACTIVATION
STRUCTURAL DOMAINS AND MOLECULAR CONTROL OF WASP
ACTIVITY
A close analysis of WASP reveals a molecular hub organized as a
five-domain structured molecule (Figure 1). The first N-terminal
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FIGURE 1 |Wiskott–Aldrich syndrome protein activation, molecular
partners, and cytoskeleton remodeling. In its basal state, the
Wiskott–Aldrich syndrome protein (WASP) is auto-inhibited due to
intramolecular interaction between its verprolin-homology domain–cofilin
homology domain–acidic region (VCA) domain and its GTPase-binding domain
(GBD). The association of WASP-interacting protein (WIP) with the WASP
homology 1 (WH1) domain stabilizes the auto-inhibited form. Upon activation
of a wide range of cell surface receptors (detailed in Figure 2), the Rho family
GTPase cell division cycle 2 (CDC42) binds to the GBD, which causes the
release of the VCA. Additional WASP activators include the
proline–serine–threonine phosphatase-interacting protein 1 (PSTPIP1) and
phosphatidylinositol-4,5-biphosphate (PIP2) that, respectively, bind the
polyproline (PPP) domain and the basic (B) domain. Stability of active WASP is
dependent on the phosphorylation status of tyrosine residue 291 (Y291),
which is regulated by Src family tyrosine kinases and the tyrosine–protein
phosphatase non-receptor type 12 (PTPN12). Active WASP binds, via its VCA,
the actin-related protein 2 and 3 (ARP2-ARP3) complex and monomeric actin
to produce a new actin branch. Dynamical actin remodeling relies on a
balance between WASP activation and degradation, the latter being regulated
by ubiquitination and mediated by the proteasome.
domain, WASP homology 1 (WH1; also defined as EVH1, for
ENA/VASP homology 1) binds to a proline repeat motif present in
WASP-interacting protein (WIP) and mediates a molecular inter-
action regarded as critical for keeping a stable and auto-inhibited
WASP conformation. The basic region also participates in the reg-
ulation of WASP conformational status, as it binds to the phospho-
inositide PIP2 (phosphatidylinositol-4,5-biphosphate), which acts
synergistically with the small GTPase Cdc42 to activate WASP (8).
The GTPase binding domain (GBD), in a non-activated state of the
WASP molecule, is found in an intramolecular hydrophobic link
with the C-terminal VCA (composed by the verprolin-homology,
central hydrophobic, and acidic regions) domain. Upon cell activa-
tion, GBD is the critical binding site for the active Cdc42-GTP, and
such an interaction leads to a conformational change that releases
the VCA domain, shifting auto-inhibited WASP to an active mol-
ecule. The proline-rich region contains several sites for binding
of Src homology 3 (SH3) domain, playing a role as a central core
for docking of various SH3 domain-containing proteins. The C-
terminal VCA forms the actin-nucleating region of WASP. It binds
both actin monomers and the Arp2/3 complex, which is composed
of seven proteins that work together to assemble branches of actin
that grow out of a pre-existing filament. Altogether, WASP bind-
ing regions provide a molecular hub for associations with several
proteins that integrate distinct signals brought together during
cellular WASP activity (7, 9).
In T cells, WASP is mainly found in a molecular associa-
tion with WIP (Figure 1), a molecule regarded as the major
controller of WASP activation (10). As shown by in vitro data,
upon TCR stimulation, WIP recruits WASP to the immunolog-
ical synapse and appears to facilitate Cdc42-mediated activation
of WASP (11). On the other hand, in vivo studies showed that
WIP favors WASP stability by working as a molecular chaperone
(12). WASP activation is also under control of the phosphory-
lation at tyrosine residue 291 within GBD (Figure 1). Mediated
by Src kinases, including Fyn and Lck, this phosphorylation acts
synergistically with Cdc42 binding to activate WASP (13) and is
likely to regulate various T cell functions (14). Therefore, dephos-
phorylation also controls WASP activity, possibly carried out by
tyrosine-protein phosphatase non-receptor type 12 (PTPN12).
As shown from mouse studies, this phosphatase interacts with
WASP via proline, serine, threonine phosphatase-interacting pro-
tein 1 (PSTPIP1) and appears to mediate inhibition of WASP-
induced immunological synapse formation (14). Additionally,
the intramolecular GBD-VCA binding is regarded as a critical
allosteric control of WASP activity, since mutations in GBD pro-
duce a constitutively active molecule that seems to directly affect
myeloid and lymphoid cells, including lymphocyte number and
proliferation, and increased T cell death and genomic instabil-
ity, as found in X-linked neutropenia patients and in a mouse
model (15–17).
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Beyond the schematic representation of Figure 1, WASP-
promoted actin nucleation appears to be regulated by interactive
stoichiometry, as biochemical studies suggest that two WASP pro-
teins provide a VCA dimer that delivers two actin monomers to the
Arp2/3 complex (18). This process occurs upon WASP recruitment
of Arp2/3 complex to inner cell membranes where they interact
with actin filaments and, after an initial conformational activation
of Arp2/3 complex, WASP proteins are dissociated and filament
branching and growth can be carried out (19, 20).
Finally, WASP activity is also regulated through degradation
(Figure 1). In vitro studies employing human T cells have shown
that TCR ligation and tyrosine phosphorylation promote WASP
cleavage by calpain and proteasomal degradation following Cbl
E3 ligase-mediated ubiquitylation (12, 21, 22). Conversely, inter-
action with WIP leads to WASP protection (12), and disruption
of the WIP–WASP partnership, due to mutations within the WH1
domain, could decrease the WASP cell pool, which forms the mol-
ecular basis for the several immune defects seen in WAS (23, 24).
The relevance of WIP for WASP stability is supported by the recent
demonstration that a patient genetically deficient in WIP showed
clinical signs similar to those typical of WAS. In addition, WASP
expression was corrected by the transduction of WIP into the T
cells from this patient (24).
INPUT SIGNALS LEADING TO WASP ACTIVATION
The multidomain nature of WASP allows a complex molecular
partnership that integrates different pathways contributing to the
T cell activation scenario. Indeed, WASP has been shown to be
activated by the triggering of numerous cell leukocyte surface
receptors including the TCR, costimulatory receptors, integrins,
and chemokine receptors. The pathways linking TCR-driven sig-
naling to WASP activation are closely related to its localization
at the immunological synapse. In vitro studies employing mouse
and human T cell–APC conjugates demonstrated that TCR stimu-
lation induces a proximal phosphorylation cascade driven by Lck,
ZAP-70, and Itk kinases (25, 26). Upon ZAP-70-induced phospho-
rylation of the transmembrane adaptor protein LAT, a complex of
scaffold proteins such as Grb-2, SLP-76, and Gads are assembled at
the inner face of plasma membrane. WASP can be recruited to this
complex through binding of its proline-rich region to SH3 domain
of Nck1 (or Nck2), a molecule that contains an SH2 domain
that allows direct interaction to tyrosine-phosphorylated SLP-76.
These interactions recruit WASP to lipid rafts and to the immuno-
logical synapse and also promote its activation by bringing it close
to the guanine exchange factor Vav1 and to membrane-bound
Cdc42 (11, 25–27). In parallel, in vitro biochemical assays revealed
that phosphorylation of human WASP at tyrosine 291 by the
Src kinase Fyn is regarded as an associated pathway for WASP
activation (28).
Signals triggered through TCR engagement also induce con-
formational activation of integrins (inside-out signaling), as seen
for the β2 integrin LFA-1 in the adhesive interaction with ICAM-1
on the APC surface. This high-affinity conformation of LFA-1 is
organized in membrane microclusters that results in further adhe-
sive strength for stable interaction and allows the intracellular
β2-chain tail to interact with the actin cytoskeleton via actin-
binding proteins, such as talin (29). Costimulatory receptors also
appear to collaborate with TCR-triggered WASP activation and
subsequent actin rearrangement at the immunological synapse.
CD28 signaling activates Vav1 and NF-AT signaling as well as actin
rearrangement in T cells, events known to improve TCR activa-
tion (30). CD2 stimulation leads to WASP proline-rich domain
binding with PSTPIP1, a SH3-containing adaptor protein, which
recruits WASP to the immunological synapse, a molecular event
that might explain the impaired actin polymerization in vitro fol-
lowing CD2 stimulation of WASP-deficient mouse T cells (31).
Chemokine receptors also bring important signal input to WASP
activation. They are G protein-coupled receptors that promote
in vitro chemotaxis of human and mouse T cells by employing a
signaling cascade that includes activation of Vav and Cdc42 and,
consequently, WASP regulation of T cell migration (32, 33).
A concept of multiple receptors involved in relaying signals,
which activate WASP can also be supported, as a recent in vitro
study revealed that about 120 transmembrane or membrane-
associated proteins can trigger actin rearrangement through acti-
vation of WAVE (WASP-family verprolin-homologous protein)
molecules (34). Adhesive and chemotactic stimuli seem to act
cooperatively in controlling WASP activation, as suggested by the
in vitro finding that fibronectin and CXCL12 promote additive
Vav phosphorylation in human T cells, contributing for maximal
migration (32). Costimulation signals also jointly work with other
receptor-triggered actin-dependent process, as recently shown that
in vitro NKG2D receptor costimulation regulates CXCL12-driven
chemotaxis in human CD8+ T cells by increasing Cdc42 activity
(35). Taken together, these findings point to a complex part-
nership constructing the signaling pathways from a coordinated
response initiated by ligation of the TCR and its partner surface
receptors toward localized WASP activation and subsequent actin
remodeling.
DECODING WASP ACTIVATORY SIGNALS INTO CELLULAR
MECHANISMS
Wiskott–Aldrich syndrome protein activation plays a pivotal role
in regulating actin dynamics following T cell stimulation. In fact,
adhesion, polarization and motility, cellular events that underscore
various main T cell functions arise as a consequence of regulated
actin rearrangements in response to TCR engagement along with
ligation of chemokine receptors and integrins (36). Nevertheless,
WASP has been reported to drive T cell activities that can be dis-
tinctly divided accordingly to their dependence or independence
on actin remodeling (Figure 2). In this context, cognate interac-
tion of T cells with APC results in a stable contact that employs T
cell-derived actin-rich membrane protrusions extending toward
the APC. This T cell activation-induced structure is the cellular
basis for immunological synapse formation (37). Molecular imag-
ing studies with human T cells have elegantly showed that actin
polymerization is dynamically responsive to TCR triggering, ini-
tiating at the TCR signaling site and further remodeled by WASP
recruitment and proximal tyrosine phosphorylation events (38).
Although we still miss a direct evidence for WASP regulation of
actin flow-driven TCR microcluster dynamics (39), WASP acti-
vation in both human and mouse T cells has been demonstrated
to be critical for the late and more stable interaction that forms
the long-lived immunological synapse (40, 41). WASP deficiency
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FIGURE 2 |Wiskott–Aldrich syndrome protein, a multiplex decoder ofT
cell activation and function. Wiskott–Aldrich syndrome protein (WASP) is
required for many functions in lymphoid immune cells. Many of these, such
as immune synapse stability, signaling, cytokine release, and migration, relate
to the role of WASP in regulating the polymerization of the actin cytoskeleton.
Other functions of WASP depend on its activity in an actin-independent way
as a transcription factor for T-bet and also in survival by controlling Bcl-2 and
Fas expression. Bcl-2, B-cell lymphoma 2 protein; CD2 CD4/8 CD28 CD58
CD80/86, cluster of differentiation; ICAM-1, intercellular adhesion molecule 1;
LFA-1, lymphocyte function-associated antigen 1; NF-AT, nuclear factor of
activated T cells; pMHC, peptide/major histocompatibility complex; pTyr,
phospho-tyrosine; T-bet, T-box transcription factor; TCR, T-cell receptor.
seems to disorganize the immunological synapse in vitro as a con-
sequence of impaired lipid raft clustering and scaffold signaling,
resulting in abnormal localized actin polymerization (11, 27).
In parallel, as the cell secretion machinery is reoriented to this
close contact site as well, this process also drives T cell effector
functions associated with cytokine secretion (helper activity) and
cytolysis (Figure 2). A mechanistic role can also be ascribed for
WASP activity on these functions, since cytotoxic T cells from WAS
patients show aberrant polarization of cytolytic granules toward
the T cell–target cell contact area (42). In addition,WASP-deficient
mouse T cells were shown to present impaired IL-2 production
and cytokine secretion (43). Actin remodeling is also reported
to regulate appropriate calcium and NF-AT signaling in T cells
(44). Moreover, active WASP appears to play a critical role in both
sustained calcium signaling (40) and NF-AT translocation (45), as
IL-2 transcription and production are impaired in WASP-deficient
mouse T cells (45, 46). Cell migration toward chemokine gradients
guides important T cell effector activities (47). These chemotac-
tic activities are actin-dependent mechanisms that employ active
WASP, as chemokine-induced migration and homing of mouse
T cells have been defined as reduced as a consequence of WASP
deficiency (33, 48).
Wiskott–Aldrich syndrome protein activation is also reported
to regulate Th1 cytokine gene transcription (Figure 2). T cells from
WAS patients showed reduced IL-2 and IFN-γ transcripts associ-
ated to impaired NF-AT translocation and T-BET transcription
following TCR/CD28 stimulation (49). Interestingly, the finding
that WASP is present within human T cell nucleus and plays a piv-
otal role in regulating histone methylation at the TBX21 promoter
(50) reveals a regulated cytoplasmic-nuclear trafficking of WASP
with direct effect on T-BET transcription and Th1 differentiation
in an actin-independent manner (51).
Wiskott–Aldrich syndrome protein activation seems also to
be involved in cell death receptor signaling (Figure 2), as some
in vitro findings indicate that death-inducing signaling complex
(DISC) assembly and Fas internalization induced by Fas signal-
ing, including in human T lymphocytes, appears to be dependent
on actin rearrangements (52). However, an actin-independent
function for WASP in Fas signaling was suggested as well. Lym-
phocytes from WAS patients have increased CD95 expression and
caspase-3 activity along with lower Bcl-2 expression (53, 54),
which paralleled spontaneous accelerated apoptosis likely trig-
gered via actin-independent mechanisms (54). Interestingly, TCR-
stimulated CD4 T cells from WASP-deficient mice, which develop
autoantibodies and glomerulonephritis, presented reduced apop-
tosis and FasL secretion (55). Altogether, these data indicate that
WASP distinctly regulates spontaneous or TCR-induced cell death
through mechanisms that include Fas/FasL signaling, control-
ling survival of normal T cells, and apoptosis of auto-reactive
T cells. Nevertheless, impairment in both regulatory activities of
WASP on T cell death can be related to immunodeficiency and
autoimmunity in WAS patients.
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These different WASP-driven cellular mechanisms might be
regulated through distinct distribution of WASP and actin dynam-
ics within subcellular compartments. Besides the localization in
conjugated T cell–APC membranes and within the T cell nucleus,
the targeting of WASP along with signaling molecules to the
endocytic pathway points to an important subcellular localiza-
tion of actin rearrangements following receptor engagement. TCR
endocytosis triggered by antigen binding in human T cells was
shown to be mediated by WASP activation upon binding to inter-
sectin 2 (56). Moreover, in vitro studies demonstrated that human
and mouse WASP bind to SNX9 (sorting nexin 9), a regula-
tor of clathrin-mediated endocytosis (57). Such a binding seems
to mediate both interaction with the PI3K pathway and CD28
endocytosis after TCR/CD28 costimulation. WASP seems to play
an essential role in this process, as both CD28 endocytosis and
actin rearrangements are impaired in WASP-deficient T cells (57).
In spite of the critical signal transduction cascades evoked by
input signals and the consequent WASP segregation into specific
cell sites, how these subcellular compartments communicate to
each other and which mechanisms control WASP trafficking (e.g.,
cytoplasm–nucleus) and its utilization from a common cellular
pool are not yet established.
DEFECTIVE WASP EXPRESSION AND DYSREGULATED T CELL FUNCTION
Cell adhesion, shaping, and migration are critical events for T cell
development and function. As T cells develop, they emigrate from
the thymus, enter in peripheral lymphoid organs, are activated
after contacting cognate APC and, ultimately, work as helper, reg-
ulatory, or cytotoxic effectors. These cellular events are under the
influence of actin dynamics. Migratory disturbances and aberrant
T cell–APC interactions are regarded as the central dysfunctions,
which underlies the immune defects reported in WAS patients (7).
Several in vitro studies revealed that the defective interaction can
be ascribed to the inability to stabilize immunological synapses,
which is linked to defects in the assembly of focused signaling (11,
27, 40), distribution of high-affinity LFA-1 (58) and T cell–APC
contact reformation (41).
Altogether, these data point out how signal inputs that link T
cell activation to actin rearrangements are critical for proper T
cell functions. Although mechanistic basis for regulation of the
actin dynamics during T cell activation are not completely under-
stood, WASP seems to be one of the critical molecules and to
play a unique role in such a process, as regarded from the several
abnormalities found in the WAS immunodeficiency (59). In fact,
as discussed below, WASP deficiency renders major T cell subsets
dysfunctional and T cell activation seems to be greatly impacted
by impaired actin dynamics.
WASP DEFICIENCY CAUSES SELECTIVE DEFECTS IN T CELL
SUBSETS
T CELL ONTOGENY AND DIFFERENTIATION
Initial studies have revealed a status of a thymic hypoplasia at post-
mortem examination of patients with WAS (60). This suggests
reduced thymic function and possible impairment of T cell devel-
opment in this pathology. Depending on the cohorts of patients
studied, T cell counts in early-aged patients were reported to be
either normal or reduced, whereas a marked T cell lymphopenia
in older patients was more systematically reported (61, 62). Recent
studies have clarified the presence of TCR repertoire perturbations
independently from the age of the WAS patients considered (63–
65). These perturbations consist in reduced TCR diversity due to
clonotypic expansions in memory CD4+ and CD8+ T cells.
Although selective pressure exerted by recurrent infections can-
not be excluded, these data argue for a defect in thymic develop-
ment and T cell generation in WAS patients. Additionally to central
defects, there is evidence that reduced T cell survival could account
for reduced lymphocyte numbers in the peripheral blood of WAS
patients. Indeed, WAS T lymphocytes appear to be abnormally
susceptible to apoptosis, potentially through up-regulation of the
FAS-mediated cell death pathway (54). The T lymphocyte com-
partment of WAS patients was further investigated by studying
the diversity of 24 TCRVβ subfamilies by CDR3 size distribu-
tion analysis (66). The results of this study clearly indicate that,
in WAS patients above 15 years of age, the frequency of skewed
TCRVβ subfamilies is abnormally high. This indicates an oligo-
clonal pattern of TCRVβ subfamilies usage in older patients with
WAS, which might result from the progressive accumulation of
antigen-specific T cell clones. Possibly, chronic antigenic stimu-
lation consecutive to the inability to properly eradicate infectious
agents could favor oligoclonality. Shrinkage of the T cell repertoire
may also result from a failure to regenerate a diversified naïve T
cell pool or from an abnormal susceptibility to apoptosis in the
periphery. All in all, there is evidence for an anticipated aging
of the T cell compartment in WAS patients that probably results
from a combination of differentiation defects and overt stimula-
tion in the periphery. As a result, the restricted T cell repertoire
and biased T cell responses will ensure a less protective coverage
against pathogens. In addition, this might favor the development
of autoimmunity.
The critical role played by WASP in the homeostasis of human
T lymphocytes is demonstrated by the in vivo selective advantage
measured in patients with secondary WAS gene mutations allow-
ing restoration of WASP expression (67). WASP re-expression and
somatic mosaicism due to spontaneous in vivo reversion occurs
in up to 11% of WAS patients (68) that in most of the cases
is a phenomenon restricted to T lymphocytes. Reversion events
restored T lymphocyte lineage characteristics as CD3-stimulated
proliferation, actin rearrangement, WASP localization, cytokine
production, and T cell receptor diversity (69–71). As a whole, these
data suggests that selective advantage conferred by WASP expres-
sion has a major impact on T cell compartment. However, it is not
clear whether the presence of somatic mosaicism correlates with
clinical improvement (70, 72).
EFFECTOR CD4+ T CELLS
Wiskott–Aldrich syndrome protein plays multiple roles in effector
CD4+ T cells since it regulates motility, immunological synapse
stability, signal integration, and cytokine production (Figure 3).
T lymphocytes from WAS patients were originally found to dis-
play reduced chemotaxis in response to the T-cell chemoattractant
stromal cell-derived factor (SDF)-1 (73). On the other hand,
WASP-deficient CD4+ T cells display increased T cell motility
upon encounter with non-cognate dendritic cells or B cells and
reduced capacity to stop following antigen recognition (58). As an
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FIGURE 3 | Defects ofT cell subsets and link to clinical manifestations. As
WASP is required for many functions, its absence results in defects of cellular
function. We have listed those impairments for humanT cell subsets that have
been described in the literature. Black arrows show the function exerted by
each T cell types, with dotted arrows to point out unknown WASP implication.
Red crosses point out the most prominent impairments described in WAS T
cells. APC, antigen-presenting cell; pMHC, peptide/major histocompatibility
complex; TCR, T-cell receptor, TGF-β, transforming growth factor β.
integrator of multiple signals arising from chemokine receptors,
integrins, and the TCR, WASP may therefore modulate differently
the motility of T cells depending on the context. As expected
from the in vitro findings, WASP-deficient CD4+ T cells from
the Was−/− murine model display abnormal trafficking and scan-
ning abilities. Indeed, the homing of WASP-deficient lympho-
cytes to Peyer’s patches is significantly impaired upon adoptive
transfer into recipient mice, when compared to wild-type lym-
phocytes (48). Although not formally demonstrated, it is highly
probable that CD4+ T cell motility defects contribute to the
immunocompromised status of WAS patients.
Like for its role in T cell motility, WASP appears as a modula-
tor of immunological synapse assembly. Rather than participating
in the initial steps of immunological synapse assembly, WASP
controls the stability of this complex structure (41). In partic-
ular, WASP is required for focused signal integration at the T
cell/APC interface and sustained calcium signaling (40). It follows
a sub-optimal T cell activation leading to decreased proliferative
capacities (74). The selective defect in Th1 cytokine production
observed in CD4+ T cell from WAS patients (75) was initially
described as a consequence of abnormal calcium signaling and
reduced nuclear recruitment of NF-AT-1 leading to defective T-
BET induction (49). However, following shuttling into the nucleus
of activated CD4+ T cells, WASP also controls T-BET activation
directly as a transcription regulator (50). These two layers of con-
trol, at the synaptic and nuclear levels, over the transcriptional
activation of Th1 cytokines in CD4+ T cells result in a marked
Th1/Th2 imbalance (49). Although this has not been precisely
evaluated, the WAS-related Th1/Th2 imbalance is expected to con-
tribute to defective activation of antigen-specific T cell responses
as well as to the pathogenesis of eczema. More in general, the
lymphocyte defects in WAS patients at least partially account for
the high susceptible to develop bacterial, viral, and fungal infec-
tions (76). A direct evidence for the contribution of T cell defective
cytokine production to the immunodeficiency was provided by the
administration to WAS patients of recombinant human IL-2 that
appeared to be effective in reducing herpes virus infection (77).
Wiskott–Aldrich syndrome protein plays a key role not only
during T cell development, activation, and functional maturation
but also during the contraction phase following T cell reactivation.
In particular, in absence of WASP, FasL release by CD4+ T cells
is reduced and this is associated with decreased TCR-mediated
apoptosis (55). Possible accumulation on CD4+ T cells after T cell
reactivation might be associated with the frequent autoimmune
complications occurring in WAS patients.
REGULATORY CD4+ T CELLS
Studies on T regulatory (Treg) cells from patients and from the
Was−/− murine model point to functional defects (Figure 3)
that most probably contribute to the development of autoimmu-
nity in WAS. WASP-deficient CD4+CD25+FOXP3+ regulatory
T cells display defective proliferation, cytokine production, and
suppressive functions (78–81). This was in particular demon-
strated in a model of colitis induced by the transfer of CD45RB+
T cells in SCID mice, in which Was−/− Treg cells were unable
to prevent the development of the inflammatory process (80).
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Evaluation of natural Treg cell development clearly showed that
WASP has a minor impact on the generation of Treg cells in the
thymus (78–81). However, in the periphery, Treg cell suppressive
function is impaired and can be partially rescued in vitro by treat-
ment with IL-2 (78, 80). These data argue in favor of defective
antigen-driven expansion and function. This is corroborated by
the observation, in a case of spontaneous revertant mutation, that
WASP-expressing Treg cells possess an in vivo selective advantage
over WASP-defective Treg cells (79).
Autoimmune complications are a frequent manifestation in
WAS patients, reaching an incidence of 72% in European and US
populations (76, 82). The most common forms are autoimmune
hemolytic anemia, cutaneous vasculitis, arthritis, and nephropa-
thy. It is tempting to speculate that the multiple autoimmune
manifestations in WAS patients arise as a consequence of a par-
tial loss of self-tolerance due to defective Treg cell function. In
parallel, intrinsic B cell dysfunction has been shown to contribute
to the emergence of auto-reactive B cells (83, 84). Interestingly,
activated Treg cells from Was−/− mice display diminished abil-
ity to induce apoptosis in B cells when compared to wild-type
ones. This impairment is associated with a significant reduction
in granzyme B degranulation from those cells and, consequently,
direct defective cytotoxicity against auto-reactive B cells (85).
Thus, the onset and development of autoimmunity in the con-
text of WASP deficiency seems to reflect the inability of Treg cells
to control the abnormal emergence of auto-reactive B cells. This
reveals an important role of WASP in regulating key cellular activ-
ities for the control of auto-reactive cells and in the maintenance
of self-tolerance.
CYTOTOXIC CD8+ T CELLS
As in CD4+ T cell subsets, CD8+ T cells from WAS patients harbor
defects in antigen-driven proliferation and cytokine production
(49) (Figure 3). WAS CD8+ T cells have a profound impairment
in the production of IL-2, IFN-γ, and TNF-α, which is due to
defective gene transcription. The block in cytokine production is
associated with reduced nuclear levels of NF-AT-1 and NF-AT-2.
Defects in antigen-specific CD8+ T cell activation and cytokine
production are also present in Was−/− mice. In this model, the
clearance of influenza A virus upon primary infection was normal,
but the secondary response was impaired (86, 87).
Wiskott–Aldrich syndrome protein deficiency affects the cyto-
toxic activity of CD8+ T cells (42). In particular,WAS patient CTLs
display a reduced cytotoxicity against tumoral B cell lines that can
be rescued by restoring WASP expression by means of a lentiviral
vector. This defect was associated to the lytic granule organiza-
tion that appeared not to fully polarize toward the center of the
CTL/tumor target cell contact area. Interestingly, cytotoxic func-
tion appears to be more profoundly affected in WASP-deficient
NK cells than in WASP-deficient CTL (88, 89). A few reasons could
account for this apparent difference, including a more pronounced
requirement of WASP in NK versus CTL for the scanning and
adhesion to target cells, the assembly of the lytic synapse, and/or
the polarized delivery of lytic granules. Along those lines, stud-
ies on WASP-deficient NK cells have helped to characterize the
assembly of a distinct NK cell lytic synapse (90, 91).
It has been proposed that combined defects in the cyto-
toxic function of CTL and NK cells could lower the level of
immunosurveillance against tumors. Initial studies have reported
tumor incidence in WAS patients to range from 13% (92) to 22%
(76). This incidence might be underestimated given the increase of
WAS patient life expectancy over the last decades. WAS-associated
tumors are mainly leukemia, myelodysplasia, and B cell lymphoma
(often EBV positive). WAS patients developing tumors belong to
the highest risk group. The historical study reported that 2 years
after diagnosis only 1 out of 21 patients had survived (92). The
selective contribution of CTL defects to the abnormally high
occurrence of tumors is difficult to establish in a context in which
NK cells have profound defects in cytotoxic activity.
As mentioned, a significant proportion of patients with WAS
present chronic viral infections, most commonly involving mem-
bers of the herpes virus family (76). Surprisingly, little is known
about the effects of WASP deficiency on antiviral immunity. Ini-
tial animal studies indicated increased susceptibility of Was−/−
mice to influenza infection, with implications on memory devel-
opment when secondary viral challenge was evaluated (86, 87).
More recently, Was−/− mice were shown to be unable to clear an
infection with the lymphocytic choriomeningitis virus (LCMV)
and to declare increased immunopathology (93). This was asso-
ciated with an intrinsic defect in the ability of CD8+ T cells to
kill target cells presenting viral epitopes combined with a reduced
priming due to the inability of DC to produce type I IFN. This is
a demonstration that intrinsic defects of cytotoxicity in Was−/−
CD8+ T cells play a significant role in the control of viral infection
in vivo.
ADDITIONAL T CELL SUBSETS
Wiskott–Aldrich syndrome protein appears to play a particularly
important role in iNKT cells. Indeed, a profound reduction of
circulating iNKT cells has been observed in WAS patients and
seemed to correlate with severity of disease (94). In agreement,
WASP is indispensable for the maturation of murine Was−/− iNKT
cells. In addition, WASP-deficient iNKT cells displayed defective
homeostasis, homing, retention within peripheral lymphoid tis-
sues and activation (94, 95). Further studies will be required
to determine whether defective iNKT cell function affects pDC
function.
Our knowledge about the role of WASP in T lymphocytes is
still incomplete. In particular, many T lymphocyte subsets remain
to be characterized in the context of WAS. Although γδ T cells
have long been described to be abundant in the peripheral blood
of WAS patients (96), their functional properties have not been
tested. It will also be of interest to investigate the role of WASP in
Th17 cells, since this T cell subset is associated to the development
of inflammatory and autoimmune disorders (97). Interestingly, a
recent study reported that exacerbated arthritis in Was−/− mice
was associated with an increase of Th17 cells and a decrease of
regulatory T cells and B cells (98). This points to a possible role of
WASP in Th17 homeostasis. Whether WASP modulates cytokine
production in those cells also remains to be assessed. Unconven-
tional Treg cell populations such as Tr1 cells and CD8+ Treg cells
might also harbor specific defects in WAS and contribute to some
clinical manifestations. Finally, WASP is also probably playing a
role in the motility, activation, and function of T follicular helper
cells, which play a crucial role in the maturation of antigen-driven
B cell responses (99).
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CONCLUDING REMARKS
Although the deficiency in WASP is extremely rare in the human
population, this protein has been one of the most studied
pathology-associated molecules in T lymphocytes. Its role in inte-
grating activation through multiple key receptors and in decod-
ing activation into actin cytoskeleton remodeling has stimulated
research interest. As a result, the elucidation of the roles played by
WASP in T cells has contributed to our understanding of T cell
activation and function.
Many key concepts that still remain to be elucidated are emerg-
ing from the study of WASP in T cells. WASP is probably activated
concomitantly by several receptors. How is signal integration per-
formed to tune local actin remodeling? WASP plays multiple
actin-dependent and actin-independent roles within the cell. How
is WASP compartmentalization regulated? Is there a coordina-
tion between different compartments such as the immunological
synapse and the nucleus? WASP appears to play slightly different
roles depending on the T cell subsets. Is this linked to the role
of WASP in the fine-tuning of T cell activation or in controlling
specific transcriptional programs?
New tools would help to answer these questions. In particu-
lar, a better visualization of WASP at work with high resolution
would be crucial. A further definition of WASP partners in differ-
ent subcellular compartments would also be required to elucidate
the diversity of WASP function. In light of the role of WASP in
tuning motility, in setting the threshold for antigen-driven stim-
ulation and in regulating specific transcriptional programs, it is
tempting to speculate that is has an impact on the developmental
plasticity of CD4+ T lymphocytes.
To unravel the contribution of specific defects to pathology,
finer models with one defect only at a time would be required.
Then, a further challenge will be to consider that WAS does not
just result from isolated T cell-intrinsic defects but from inter-
related defects. In addition to the T cell intrinsic defects reviewed
here, it is important to underline the extrinsic defects of T cell
activation by APC (100, 101).
Beyond the scientific interest in elucidating the multifac-
eted role of WASP lies the prospect of improving the diag-
nosis and the treatment of WAS. As part of the develop-
ment of gene therapy approaches, the understanding of the
role played by WASP in setting the threshold for TCR-driven
proliferation and IL-2 production has provided a robust read-
out to compare the efficacy of WASP-encoding retroviral vec-
tors (102, 103). This has also recently been used to assess
restoration of T cell function in the WAS patients enrolled
in the first gene therapy trials (63, 104). The follow-up of
gene therapy treated patients as well as patients with sec-
ondary mutations leading to WASP re-expression in T cells
(70) will also allow us to more precisely link WASP-dependent
molecular control of T cell function to physiological immune
responses.
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